BRBS · Blue Ridge Bankshares, Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on May 3, 2021; bars on opposite sides are not compared.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Banks - Regional — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRBS
this stock
Blue Ridge Bankshares, Inc.
|
$366.83M | -4.2% | +124.0% | 37.2 | 2.0% |
|
MFG
Mizuho Financial Group Inc
|
$138.58B | +56.4% | — | — | 0.1% |
|
HDB
Hdfc Bank Ltd
|
$119.92B | -36.1% | -3.2% | — | 0.7% |
|
CIXPF
CaixaBank/ADR
|
$107.26B | +26.7% | — | — | 0.1% |
|
IBN
Icici Bank Ltd
|
$105.48B | -1.4% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on May 3, 2021; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BRBS | +3.5% | +9.1% | +3.5% | +4.9% | -4.2% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | +4.7% | +10.8% | -14.3% | +5.2% | -16.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.